0
0
Read Time:9 Second
Natco Pharma Limited has informed the Exchange regarding a press release dated March 03, 2026, titled “NATCO announces launch of Pomalidomide Capsules (generic of Pomalyst®) in the U.S. market”. |SUBJECT: Press Release
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %